Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
Di | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market | 2 | GlobeNewswire (USA) | ||
20.06. | Shuttle Pharmaceuticals raises $4.25 million in private placement | 1 | Investing.com | ||
20.06. | Shuttle Pharmaceuticals sammelt 4,25 Millionen US-Dollar durch Privatplatzierung ein | 2 | Investing.com Deutsch | ||
20.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market | 2 | GlobeNewswire (USA) | ||
12.06. | Shuttle Pharmaceuticals plant Aktienzusammenlegung im Verhältnis 25:1 | 2 | Investing.com Deutsch | ||
12.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative | 125 | GlobeNewswire (Europe) | GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
04.06. | Shuttle Pharma ernennt neuen Vorstandsvorsitzenden | 2 | Investing.com Deutsch | ||
04.06. | Shuttle Pharma appoints new Chairman to its Board | 3 | Investing.com | ||
04.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors | 1 | GlobeNewswire (USA) | ||
15.05. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Corporate Update | 180 | GlobeNewswire (Europe) | GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
15.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.05. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
08.05. | Shuttle Pharma erreicht Halbzeitmarke bei Glioblastom-Studie | 3 | Investing.com Deutsch | ||
21.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 | 1 | GlobeNewswire (USA) | ||
10.04. | Shuttle Pharma reicht Patent für Krebsbehandlungsinnovation ein | 1 | Investing.com Deutsch | ||
10.04. | Shuttle Pharma files patent for cancer treatment innovation | 2 | Investing.com | ||
10.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer | 104 | GlobeNewswire (Europe) | Filing provisional patent application with the USPTO entitled "PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy" key to advancement of Diagnostic and Therapeutic programs Dr. Alan... ► Artikel lesen | |
25.03. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.03. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INNOCAN PHARMA | 0,142 | -3,08 % | Innocan Pharma kündigt Präsentation eines narrativen Reviews zu synthetischem Cannabidiol mit Langzeitwirkung bei chronischen Schmerzen im Rahmen der Konferenz PAINWEEK an | Herzliya, Israel und Calgary, Alberta - 20. Juni 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) ("Innocan" oder
das "Unternehmen"), ein Vorreiter auf dem... ► Artikel lesen | |
ARZNEIWERK AG VIDA | 0,640 | +5,79 % | PTA-News: Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien | DJ PTA-News: Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien
Unternehmensmitteilung für den Kapitalmarkt
Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien
Berlin (pta000/16.06.2025/12:00... ► Artikel lesen | |
CRESCO LABS | 0,430 | -2,01 % | Cresco Labs Inc: Cresco Labs terminates auditor Marcum | ||
CSPC PHARMA | 0,853 | -0,84 % | CSPC PHARMA (01093): NOMINATION COMMITTEE - TERMS OF REFERENCE | ||
TONIX PHARMACEUTICALS | 30,000 | -1,32 % | Pre-market Movers: Creative Global Technology, Liminatus Pharma, CureVac, Jupiter Neurosciences, Tonix Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.05 A.M. ET).In the Green Creative Global Technology Holdings Limited (CGTL)... ► Artikel lesen | |
AMARIN | 13,600 | +3,82 % | Recordati: RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA IN EUROPE | RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
Vazkepa® supported by strong clinical data package and expected to contribute to Specialty... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 24,400 | -3,75 % | XFRA ITH0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNEKTAR THERAP. NEW... ► Artikel lesen | |
JAGUAR HEALTH | 2,760 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset | Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,710 | -0,56 % | XORTX Therapeutics Inc (3): XORTX arranges $925,000 (U.S.) private placement | ||
NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Q2 2024: Umsatzrückgang während Positionierung für Psychedelika-Zulassungen | ||
CANNOVUM CANNABIS | 0,211 | -17,25 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen | |
TALPHERA | 0,410 | +9,79 % | Talphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025... ► Artikel lesen | |
BETTERLIFE PHARMA | 0,053 | 0,00 % | BetterLife Pharma Inc. - 6-K, Report of foreign issuer | ||
MEDIPHARM LABS | 0,050 | +7,73 % | MediPharm Labs Corp.: MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders | TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
VIRACTA THERAPEUTICS | 0,019 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 10.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.02.2025ISIN NameES0105015012 LAR... ► Artikel lesen |